Taking a Look at Corbus Pharmaceuticals in the Latest NICILytics Showcase

Lifetime members just gained access to the latest NICILytics Showcase…

This past Thursday, Greg Miller, Executive Director of the National Institute for Cannabis Investors, sent out the latest NICILytics Showcase.

In these weekly reports, Greg takes a deep-dive into the database’s different companies.

From the highest rated companies, to the lowest, across every different subsector, you’ll get Greg’s personal thoughts on every aspect of the featured company.

This week, Lifetime members are getting a closer look at Corbus Pharmaceuticals Holdings Inc. (Nasdaq: CRBP), a company with some very risky operations.

Access the full report here for the full story.

To your investing success,

NICI Staff Reports

---

Comments

One response to “Taking a Look at Corbus Pharmaceuticals in the Latest NICILytics Showcase”

1. got. some. plan to hold on.

   Reply